Showing 1 - 5 results of 5 for search 'N. Kanellias', query time: 0.02s
Refine Results
-
1
S178: SAFETY AND EFFICACY OF BELANTAMAB MAFODOTIN IN COMBINATION WITH RD IN NEWLY DIAGNOSED, TRANSPLANT INELIGIBLE MULTIPLE MYELOMA PATIENTS: A PHASE 1/2 STUDY BY THE HELLENIC SOCI... by E. Terpos, M. Gavriatopoulou, I. Ntanasis-Stathopoulos, P. Malandrakis, D. Fotiou, N. Kanellias, S. Gkolfinopoulos, K. Manousou, E. Kastritis, M.-A. Dimopoulos
Published 2022-06-01
Article -
2
B08: A THIRD BNT162B2 DOSE INDUCES ANTIBODY RESPONSES AGAINST SARS-COV-2 EVEN IN PREVIOUSLY NON-RESPONDERS WITH MULTIPLE MYELOMA by E Terpos, M Gavriatopoulou, I Ntanasis-Stathopoulos, A Briasoulis, S Gumeni, P Malandrakis, E-D Papanagnou, M Migkou, N Kanellias, E Kastritis, I P Trougakos, M A Dimopoulos
Published 2022-04-01
Article -
3
P14 OCULAR TOXICITY IN TRANSPLANT INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH BELANTAMAB MAFODOTIN, LENALIDOMIDE AND DEXAMETHASONE IN A PHASE 1/2 TRIAL by I. Ntanasis-Stathopoulos, M. Gavriatopoulou, P. Malandrakis, D. Fotiou, N. Kanellias, M. Migkou, F. Theodorakakou, V. Spiliopoulou, R. Syrigou, E. Eleutherakis-Papaiakovou, S. Gkolfinopoulos, K. Manousou, E. Kastritis, M.A. Dimopoulos, E. Terpos
Published 2023-05-01
Article -
4
P1230: PET/CT IMAGING FOR RESPONSE ASSESSMENT AND TREATMENT GUIDANCE AFTER RITUXIMAB-DOSE-ADJUSTED-EPOCH(R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL):THE GREEK... by T. Vassilakopoulos, A. Piperidou, Z. Mellios, E. Verigou, C. Kalpadakis, E. Katodritou, S. Papageorgiou, C. Chatzidimitriou, C. Giatra, T. Leonidopoulou, V. Xanthopoulos, S. Karakatsanis, G. Gainaru, E. Vrakidou, A. Koumarianou, E. Hatzimichael, E. Verrou, M. Tsirogianni, I. Drandakis, M. A. Lefaki, A. Liaskas, A. Kopsaftopoulou, P. Lampropoulou, N. Kanellias, P. Zikos, D. Liapi, G. Karianakis, D. Grentzelias, E. Papadaki, M. Siakantaris, P. Tsirigotis, F. Panitsas, E. Plata, M. Bakiri, I. Datseris, S. Chatziioannou, V. Prassopoulos, E. Skoura, M. Angelopoulou, A. Symeonidis, T. Karmiris, P. Rontogianni
Published 2022-06-01
Article -
5
P1229: RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): REAL-LIFE EXPERIENCE ON 225 PATIENTS FROM 4 COUNTRIES by T. Vassilakopoulos, B. Ferhanoglu, N. A. Horowitz, J. Apostolidis, Z. Mellios, L. Kaynar, M. Zektser, A. Symeonidis, A. Piperidou, C. Kalpadaki, O. M. Akay, S. C. Atalar, A. Sayyed, E. Katodritou, T. Leonidopoulou, S. Papageorgiou, T. Tadmor, O. Gutwein, S. Karakatsanis, C. Ganzel, G. Karianakis, G. Isenberg, G. Gainaru, E. Vrakidou, M. Palassopoulou, M. Ozgur, M. Siakantaris, S. Paydas, P. Tsirigotis, M. Tsirogianni, E. Hatzimichael, T. F. Tuglular, C. Chatzidimitriou, A. Liaskas, M. A. Lefaki, N. Kanellias, P. Zikos, A. Koumarianou, A. Gafter-Gvili, M. Angelopoulou, T. Karmiris, R. Gurion
Published 2022-06-01
Article